Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Wolfe on Nebius (NBIS) Amid 19% Gain: 'We think contracted capacity turning active is difficult to underwrite'
May 13, 2026 1:45 PM EDTWolfe Research analyst Arsenije Matovic reiterated a Peerperform rating and {REMOVEPT} price target on Nebius Group (NASDAQ: NBIS).
The analyst comments "Overview. NBIS reported 1Q results with revenue of $399M, up 684% Y/Y (+6% vs. cons.), and ARR reaching $1.9B, up >50% Q/Q, supported by added capacity, increased utilization, and higher pricing. NBIS raised FY26 CapEx guidance by $4.5B at the midpoint to $20-25B, driven by FY27 demand visibility rather than component costs, while reiterating FY26... More
